OBJECTIVES: Right heart failure (RHF) after the implantation of a left ventricular assist device (LVAD) remains a dreaded postoperative complication. Using 2D speckle-tracking echocardiography, it is possible to acquire right ventricular global and regional function. The aim of our study was to assess whether speckle-tracking echocardiography values will better predict the RHF post-continuous-flow LVAD implantation.
INTRODUCTION
Continuous-flow left ventricular assist devices (CF-LVADs) are increasingly used as a therapy option in patients with end-stage heart failure, both as a bridge to cardiac transplantation and as a destination therapy [1] . Even though CF-LVADs show lower occurrences of right heart failure (RHF) than earlier pulsatile flow devices [2] , RHF remains one of the severest complications after CF-LVAD implantation [3, 4] along with bleeding, infections and neurological deficits. Due to heterogeneous cohorts and the lack of a universally valid definition, the occurrence of RHF after CF-LVAD implantation ranges between 5% and 44% [1, [3] [4] [5] . Still there is no reliable way to identify those patients who are at risk for postoperative RHF [5] [6] [7] [8] , because only a few preoperative risk factors have proven to be useful in several independent studies [9] . Transthoracic echocardiography (TTE) is a generally available non-invasive imaging modality that can assess right ventricular (RV) structure and function with a variety of quantitative measures, such as fractional area change (FAC), deformation imaging with strain and strain rate analyses and tricuspid annular plane systolic excursion (TAPSE) [10, 11] . Two-dimensional (2D) speckletracking echocardiography, which works independently of angle and is not influenced by tethering effects [12, 13] , is a useful technique to obtain information concerning RV longitudinal function [13] . Using 2D speckle-tracking echocardiography, it is possible to acquire RV strain and strain rate, which seem to be quite reliable in the quantification of global and regional RV function [14] . Furthermore, 2D strain analysis has the advantage of being relatively independent of the RV preload and afterload [15, 16] .
This study aims to identify the common risk factors for RHF after CF-LVAD implantation with a special focus on strain and strain rate analysis.
MATERIALS AND METHODS

Patient data
All patients who underwent CF-LVAD implantation from January 2014 until January 2016 at our institution were retrospectively reviewed. Patients were excluded only from the echocardiography analyses if they did not have a preoperative TTE, performed at our institution before CF-LVAD implantation or if the image quality of the TTE precluded accurate RV assessment. Detailed demographic and medical history data were obtained from the electronic medical database of our institution. Blood samples were taken from all patients between 24 and 48 h before surgery and sent to the clinical laboratory for routine preoperative testing [complete blood count, liver function testing, renal function testing, international normalized ratio, partial thromboplastin time and inflammatory parameter such as procalcitonin (PCT)]. Haemodynamic measurements through right and left heart catheterization were obtained 7-5 days prior to surgery and included cardiac index, right ventricular systolic pressure (RVSP), mean pulmonary artery pressure, post-capillary wedge pressure, left ventricular ejection fraction, left ventricular pressure and pressure in the aorta. The Michigan Risk Score and the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) were charged for each patient [6, 17] . Informed consent was waved by our ethics committee (Ethik-Kommisison, RWTH Aachen) due to the retrospective nature of the study. Ambulatory LVAD patients were routinely followed up every 2 months from February 2014 until January 2017, according to our standardized follow-up protocol for LVAD patients.
Right heart failure definition
We decided to base our definition of RHF on the INTERMACS definition prior to 2014 [17] : The INTERMACS define RHF as (i) the need for an RV assist device or (ii) the requirement of inhaled nitric oxide or inotropic therapy for >1 week any time after LVAD implantation in the presence of symptoms and signs of persistent RV dysfunction, such as central venous pressure (CVP) >18 mmHg with a cardiac index <2.3 l/min/m 2 in the absence of elevated left atrial or pulmonary capillary wedge pressure >18 mmHg, cardiac tamponade, ventricular arrhythmias or pneumothorax [2, 17] .
Transthoracic echocardiography
Two-dimensional colour flow, continuous-, pulsed-Doppler TTE studies were performed with GE Vivid E9 (GE Vingmed Ultrasound AS, Horten, Norway) according to the EACVI/ASE guidelines [18] . The studies were then analysed offline with EchoPAC version 113 (GE Vingmed Ultrasound AS, Horten, Norway) by a single sonographer blinded to patient outcomes. In addition to the RV functional assessment in modified apical 4-and 3-chamber views with TAPSE, RV-FAC, RV wall thickness according to the ASE/EAE guidelines [10] , strain and strain rate analyses were also performed to estimate the global longitudinal strain of the RV, longitudinal strain rate of the RV, peak systolic longitudinal strain of the RV free basal wall (PSLS basal ) (Fig. 1 ).
Statistical analysis
Categorical variables are presented as absolute numbers and percentages, while continuous variables are expressed as the mean ± SD. Univariable analyses were performed using the Mann-Whitney U-test for continuous variables (due to nonnormally distributed data) and the Fischer's exact test for the categorical variables to perform between-group comparisons for those patients with RHF and those without. Odd ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Area under the curve (AUC) was determined using the receiver-operator characteristics analysis. All statistical comparisons were 2-sided. For all analyses, P < 0.05 was considered statistically significant and a univariable predictor of RHF after CF-LVAD implantation. Backward and forward stepwise logistic regression analyses were performed for all variables on the univariable predictors, with an entry criterion of a P-value <0.05. Kaplan-Meier survival curves were generated using the log-rank test. Posterior power analysis was performed to detect the effect size with the given sample size.
RESULTS
From January 2014 to January 2016, a total of 54 patients received a CF-LVAD at our department. Ten Patients with incomplete echocardiography data sets were excluded only from echocardiography analysis. Most of the 54 patients received the HeartMate II (St. Jude Medical, Minneapolis, MN, USA) (81%), 13% the HeartWare (HeartWare Inc., Framingham, MA, USA), 6% the HeartMate 3 (St. Jude Medical).
Incidence of right heart failure
Thirteen patients (24.1%) developed RHF post-CF-LVAD implantation. These patients were classified as suffering from RHF due to the requirement of right-sided extracorporeal membrane oxygenation (2 of 13; 15.4%), prolonged treatment with positive inotropic agents (8 of 13; 61.5%), inhalative vasodilatator dependence (inhaled nitric oxide) for more than 7 days (3 of 13; 23.1%) or clinical signs of symptomatic and persistent RHF (2 of 13; 15.4%). Consequently, 15.4% suffered from severe RHF, 61.7% from moderate RHF and 23.1% of the patients from mild RHF.
Risk factors associated with right heart failure in univariable analyses
Demographics and laboratory. Table 1 displays the preoperative clinical characteristics and laboratory data. In the univariable analyses, the group of patients suffering from RHF showed significantly elevated PCT (ng/ml; P = 0.011; OR = 1.39; 95% CI: 0.37-5.16; AUC: 0.76) and significantly reduced haemoglobin (Hb; g/dl ; P = 0.010; OR = 0.96; 95% CI: 0.94-0.99; AUC: 0.74) levels. Using the cut-off for PCT of 0.09 ng/ml developed by Canbay et al. [19] on our patients, 70% in the RHF group and only 12% of the No-RHF group showed values over that cut-off. Likewise, they presented a higher Michigan Risk Score (P = 0.001; OR = 2.36; 95% CI: 1.41-3.95; AUC: 0.70). In addition, the indication 'bridge to transplantation' was predominant in the group of patients who did not develop postoperative RHF (No-RHF vs RHF, 19 vs 1; P = 0.019).
Haemodynamics. Table 2 summarizes the preoperative haemodynamics. With reference to haemodynamics, only an increased RVSP (44.0 ± 13.7 vs 58.2 ± 18.4 mmHg; P = 0.016; OR = 1.06; 95% CI: 1.01-1.10; AUC: 0.74) and an increased pulmonary artery systolic pressure (PASP) (44.6 ± 15.3 vs 58.1 ± 14.6 mmHg, P = 0.013; OR = 1.05; 95% CI: 1.01-1.09; AUC: 0.75) turned out to be significant. RHF was more often associated with preoperative requirement of catecholamine support (P = 0.043).
Echocardiography. TTE measurements are presented in Table   3 . RHF was associated with decreased PSLS basal (-20.7% vs -14.9%; P = 0.032; OR = 1.09; 95% CI: 1.01-1.18; AUC: 0.71). Furthermore, global longitudinal strain of the RV below -13% was significantly more often associated with RHF than values over -13% (P = 0.015; OR = 7.00; 95% CI: 1.28-38.35). Other measurements of systolic RV function (TAPSE and RV-FAC) did not differ between groups (Table 3 ).
Perioperative data. Table 4 LVAD implantation showed the relevance of central venous pressure. There was a significant difference between patients without and with RHF directly before implantation (CVP measured before insertion of heart lung machine's cannula; 13.5 ± 5.2 vs 18.6 ± 4.0 mmHg; P = 0.002; OR = 1.19; 95% CI: 1.05-1.35; AUC: 0.81). Similarly, the CVP immediately after LVAD implantation (CVP measured after closure of the sternum in the operating room) were higher in the group RHF (13.4 ± 3.5 vs 17.3 ± 5.1 mmHg; P = 0.031; OR = 1.25; 95% CI: 1.06-1.47; AUC: 0.72). In addition, patients with RHF received significantly more packed red blood cells during surgery and on the following day than the other group (4.2 ± 3.0 vs 6.5 ± 2.2; P = 0.008; OR = 1.291; 95% CI: 1.02-1.63). As opposed to patients without RHF, patients with RHF often required 20 or more IU of positive inotropic support to provide RV output (9 vs 44%; P = 0.002) postoperatively. Additionally, patients of the RHF group showed significantly higher CVP values (29% of the days during intensive care unit >18 mmHg vs 9%, P = 0.034).
Mortality. Seven patients with RHF died within the first 30 days, while 3 patients without RHF died (53.8 vs 7.3%; P = 0.001). The 6-month mortality in the RHF group was 69.2%, whereas in the No-RHF group it amounted to only 24.4% (P = 0.001). KaplanMeier survival analyses revealed a significant difference in survival among RHF and No-RHF groups [log-rank (Mantel-Cox) test; P = 0.001; Fig. 2 ].
Multivariable analyses. After entering all variables, which were significant (P < 0.05) in the univariable analysis, into a multivariable regression model and after backward and forward selection, Hb, PCT, PSLS basal , pre-CVP and RVSP entered the final model. Only PSLS basal (P < 0.001; OR = 1.26; 95% CI: 1.12-1.43) and the pre-CVP (P < 0.001; OR = 1.41; 95% CI: 1.19-1.67) remained a significant predictor of RHF, while other variables Hb (P = 0.192, OR = 0.95; 95% CI: 0.87-1.02), PCT (P = 0.043; OR = 0.12; 95% CI: 0.12-1.48) and RVSP (P = 0.521; OR = 1.03; 95% CI: 0.94-1.13) did not show a significant effect of developing RHF after LVAD implantation in this multivariable regression analysis.
With this final regression model, the sensitivity and specificity reached 85.71% and 95.45%, respectively, and the positive predictive value was 66.78% with a negative predictive value of 95.45% and the AUC was 0.92. The receiver-operating characteristic curve of the final regression model is presented in Fig. 3 . Due to the small group of RHF patients and the few variables, which remained significant after the multivariable analysis, PRBCs: packed red blood cells given perioperatively and during the first 12 h postoperatively; pre-CVP: CVP measured directly before cannulation of the heart-lung machine; FFP: fresh frozen plasma; CVP: central venous pressure; iNO: inhaled nitric oxide; MAP: mean arterial pressure; ICU: intensive care unit; RHF: right heart failure; CI: confidence interval; AUC: area under the curve; OR: odds ratio.
we did not perform further analyses to develop a risk score predicting the RHF after LVAD implantation.
DISCUSSION
In the present study, we confirmed a high mortality rate associated with RHF in patients receiving CF-LVAD. Still predicting RHF remains a challenging topic in the era of CF-LVAD. Until today, the definition of RHF does not include any parameters of RV function. In this regard, echocardiographic measurements might be a useful supplement for RHF definition [2, 10, 14] . Besides the literature reporting on RV function assessment prior to LVADs implantation using speckle tracking is growing [2, 11, 13, 14] . The findings and other known risk factors for the development of RHF after CF-LVAD implantation are summarized in Supplementary Material, Table S1 . Neither prior cardiac surgery, INTERMACS level, aetiology of the heart failure nor pulmonary diseases or age at the time of CF-LVAD implantation had any influence on the development of post-LVAD RHF in our study. Other studies observed a correlation of RHF with female patients, non-ischaemic aetiology and preoperative circularity support [7, 8, 20, 21] , which could not be verified by our data. However, the preoperative requirement of catecholamine was associated with RHF postoperatively in our study.
Kormos et al. and Matthews et al. suggested that laboratory data might be more meaningful than pre-LVAD haemodynamic data in predicting RHF [6, 21] . In our study, both PCT and Hb were significantly different between the 2 groups. In literature, PCT is increasingly discussed as a marker of congestive or decompensated heart failure and mortality in acute heart failure patients [19, 22] . Thus, our findings indicate a potential correlation between RHF and elevation of PCT, confirming the results of Hennig et al. [23] .
Besides patients with RHF presented significantly lower Hb values, reflecting the importance of improving anaemia in heart failure patients prior to cardiac surgery in order to reduce perioperative complications [8] . We could also confirm that the Michigan Risk Score is a useful predictor of RHF [5, 6] .
Only few haemodynamics proved to be significantly associated with RHF in several different studies: A low mean pulmonary artery pressure [20] , an elevated pulmonary vascular resistance [2] and transpulmonary pressure gradient [16] as well as an increased CVP [7] and CVP/pulmonary capillary wedge pressure ratio [21] were claimed to be predictive for RHF post-LVAD implantation.
Contrary to our findings, a low PASP was considered to predict RHF in heart failure populations with extreme RV dysfunction in previous studies [2, 4, 20] . Hayek et al. [2] already questioned the relevance of PASP due to its limited value in patients with moderate or mild RV dysfunction who represent the main acceptors of LVADs. On the other hand, Puwanant et al. [24] supported our findings, showing a correlation between an elevated PASP and RHF. This apparent contradiction could be attributed to different amounts of RV dysfunction and pulmonary hypertension between the study cohorts. Other explanations are the use of different LVAD types or variable postoperative adjustment of the LVAD [24] . Moreover, our data indicated an association between elevated RVSP and post-LVAD RHF, which might be a sign of reduced preoperative RV ejection fraction [24] .
According to Hayek et al. [2] , different echocardiographic parameters showed a correlation with RHF, including TAPSE, RV ejection fraction, RV end-diastolic diameter, tricuspid regurgitation, RV-FAC, RV systolic pressure, RA pressure, visual RV dysfunction and strain parameters of RV. Unfortunately, rarely a parameter was confirmed by more than one study group. For example, the TAPSE, which is an easily gathered parameter for RV longitudinal function [10] , was measured in nearly every study but only proved to be significant in 2 of the 8 studies [2, 24] .
The only significant correlation with RHF in our study could be detected in a decreased basal longitudinal systolic strain of the RV free wall (PSLS basal ). Our findings support Hayek et al., Grant et al. and Cameli et al. [2, 5, 11] who found that a reduction of global RV longitudinal and/or free wall RV longitudinal strain values correlate well with postoperative RHF.
Our data showed a higher application of packed red blood cells in the group RHF than in the group No-RHF. While Grant et al. [5] assumed that an extensive perioperative use of blood products and fluids may cause RV distension, Matthews et al. [6] proposed that RV dysfunction by itself leads to an increased requirement of transfusion. As Dandel et al. [25] appropriately stated, it is necessary to identify patients at risk of post-LVAD RHF at the latest during LVAD surgery. In this regard, we observed significantly higher CVP values during surgery (but before cardiopulmonary bypass and LVAD implantation) in patients developing a postoperative RHF. Likewise, the intraoperative CVP after LVAD implantation and cardiopulmonary bypass showed higher values in patients with RHF than in patients without RHF. These findings suggest that it is advisable to check the CVP intraoperatively before cardiopulmonary bypass and if necessary (significantly increased CVP) implant a biventricular assist device/RV assist device + LVAD instead of a solitary LVAD.
In our study, cardiopulmonary bypass time had no influence on the development of RHF postoperatively.
RHF leads to increased morbidity, mortality and longer hospital stays [1-3, 7, 24] . This is confirmed by our data. In our study, patients with RHF showed a worse postoperative development characterized by augmented requirement of positive inotropic treatment and higher mortality rates within the first 30 days post-LVAD implantation than patients without RVF. While 82% of the patients without RHF survived the first 6 months post-LVAD implantation, only 41% of the RHF group survived so far.
Patients with RHF depended on larger quantities of inotropic support, exceeding 20 IU, significantly more often than patients without RHF (1 day vs 6 days during intensive care unit stay). Moreover, 76% of patients with RHF required inotropic support beyond Day 14 post-LVAD implantation as opposed to 12% in the group without RHF.
Limitations
Due to the retrospective nature of our study, our research was subject to potential bias in patient selection and data acquisition. The TTEs used for our study were performed for clinical indications and were often not obtained immediately before LVAD placement. In addition, not all studies included sufficient data for complex RV assessment, which is why 10 patients had to be excluded from the TTE analyses. Another limitation was the relatively small number of patients in this single-centre approach, which may limit generalization of the results. With the given sample sizes of n = 41 (non-RHF) and n = 13 (RHF), the power to detect an effect size of 0.925 at a significance level of 0.05 is 0.8 (2-sided Mann-Whitney U-test). For dichotomous variables, the power of 0.8 is achieved for proportions 67.5 vs 20.0% (non-RHF vs RHF) or 50.0 vs 7.7%, to give 2 examples (2-sided Fisher's exact test). Smaller effect sizes are less probable to be detected with the given data set. Given these limitations, validation with larger patient samples will be required.
CONCLUSIONS
No single independent risk factor is reliable enough to stratify patients preoperatively. 2D strain parameters of the RV free wall seem to be auspicious in adjusting RV function and predicting RHF. Moreover, intraoperative CVP should not be neglected since elevated values proved to be highly associated with RHF. The combination of echocardiographic and intraoperative factors might lead to an authentic estimation of RV function. Further assessment, preferably through large cohort multicentre studies is needed to prove this hypothesis.
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